AMY OLSEN: Open Payments
NPI 1598991275 · VERNAL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 28 payments from 12 companies in 2025. Trend: 2023 $326 · 2024 $397 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $197 |
| Amgen Inc. | 2 | $83 |
| Corcept Therapeutics | 4 | $66 |
| Organon LLC | 2 | $47 |
| Merck Sharp & Dohme LLC | 3 | $45 |
| ABBVIE INC. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: AIRSUPRA, EVENITY, Korlym, FARXIGA, NEXPLANON, VERQUVO, BREZTRI, QULIPTA.
Industry payments across UT — which companies pay providers there.
